<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:News="http://www.bing.com/news/search?q=migraine%26drug&amp;format=rss"><channel><title>migraine&amp;drug - BingNews</title><link>http://www.bing.com/news/search?q=migraine%26drug&amp;format=rss</link><description>Search results</description><image><url>http://www.bing.com/rsslogo.gif</url><title>migraine&amp;drug</title><link>http://www.bing.com/news/search?q=migraine%26drug&amp;format=rss</link></image><copyright>Copyright \xc2\xa9 2026 Microsoft. All rights reserved. These XML results may not be used, reproduced or transmitted in any manner or for any purpose other than rendering Bing results within an RSS aggregator for your personal, non-commercial use. Any other use of these results requires express written permission from Microsoft Corporation. By accessing this web page or using these results in any manner whatsoever, you agree to be bound by the foregoing restrictions.</copyright><item><title>Go-to migraine drug actually does nothing to relieve vertigo symptoms</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e49f82016d4283a4f533fe1abddd9e&amp;url=https%3a%2f%2fwww.msn.com%2fen-us%2fhealth%2fother%2fgo-to-migraine-drug-actually-does-nothing-to-relieve-vertigo-symptoms%2far-AA1ECJy9&amp;c=6253874761571738202&amp;mkt=en-us</link><description>A medication commonly prescribed for migraines actually seems to do little to ease vestibular ones, which cause vertigo, along with more typical symptoms like headache and sensitivity to light. This ...</description><pubDate>Mon, 12 May 2025 08:25:00 GMT</pubDate><News:Source>MSN</News:Source></item><item><title>Common triptan mistakes: Why your acute migraine treatment might not be working</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e49f82016d4283a4f533fe1abddd9e&amp;url=https%3a%2f%2fwww.msn.com%2fen-us%2fhealth%2fother%2fcommon-triptan-mistakes-why-your-acute-migraine-treatment-might-not-be-working%2far-AA218Oj8&amp;c=9453407047904725915&amp;mkt=en-us</link><description>If triptans aren't alleviating your migraine attacks, learn what might be going wrong, from poor timing and low dosages to gastric stasis, and learn expert tips for better pain relief.</description><pubDate>Fri, 17 Apr 2026 08:03:46 GMT</pubDate><News:Source>Everyday Health on MSN</News:Source><News:Image>http://www.bing.com/th?id=ONUT.OGbVw4Aho545RmKVBLMVGQ&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1440</News:ImageMaxWidth><News:ImageMaxHeight>810</News:ImageMaxHeight></item><item><title>Migraines resistant to treatment could be CURED with blood pressure pill that ramps up ‘brain cleansing’</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e49f82016d4283a4f533fe1abddd9e&amp;url=https%3a%2f%2fwww.thesun.co.uk%2fhealth%2f38757495%2fmigraines-cured-blood-pressure-pill-ramps-brain-cleansing%2f&amp;c=18278333069273158762&amp;mkt=en-us</link><description>A TWICE daily blood pressure tablet may help keep migraines at bay, research suggests. The drug prazosin, which is not commonly prescribed on the NHS, typically works by relaxing blood vessels to ...</description><pubDate>Wed, 08 Apr 2026 06:06:00 GMT</pubDate><News:Source>The Sun</News:Source><News:Image>http://www.bing.com/th?id=ONUT.HCtyrejTPapPJAI6wFKjFA&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1920</News:ImageMaxWidth><News:ImageMaxHeight>1080</News:ImageMaxHeight></item><item><title>This Drug Reduces Symptoms Before a Migraine Strikes, Study Shows</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e49f82016d4283a4f533fe1abddd9e&amp;url=https%3a%2f%2fwww.yahoo.com%2fnews%2fdrug-reduces-symptoms-migraine-strikes-150044081.html&amp;c=7025787699460306519&amp;mkt=en-us</link><description>A migraine drug called ubrogepant doesn't just reduce the severity of a migraine attack – it also dials down the non-headache symptoms in the prodrome: the hours leading up to the main event. That's ...</description><pubDate>Mon, 12 May 2025 08:01:00 GMT</pubDate><News:Source>Yahoo</News:Source></item><item><title>New migraine drug affordably priced at only $6,900 a year</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e49f82016d4283a4f533fe1abddd9e&amp;url=https%3a%2f%2fwww.wdef.com%2fnew-migraine-drug-affordably-priced-at-only-6900-a-year%2f&amp;c=15714095280464607198&amp;mkt=en-us</link><description>The high cost of prescription drugs is a hot topic in the U.S., a factor likely on the minds of Amgen executives in setting the price of a new treatment for migraine headaches. The drug, to be sold ...</description><pubDate>Thu, 17 May 2018 17:00:00 GMT</pubDate><News:Source>wdef.com</News:Source></item><item><title>AbbVie migraine drug found more tolerable than competitive treatment</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e49f82016d4283a4f533fe1abddd9e&amp;url=https%3a%2f%2fwww.chicagobusiness.com%2fhealth-pulse%2fabbvie-migraine-drug-more-tolerable-competition-study&amp;c=813860394886024577&amp;mkt=en-us</link><description>AbbVie beat out a competitor's migraine-fighting drug in terms of dose tolerability in a head-to-head study. The North Chicago-based drugmaker said its Phase 3 study of atogepant (Qulipta) in a ...</description><pubDate>Fri, 20 Jun 2025 03:52:00 GMT</pubDate><News:Source>Crain's Chicago Business</News:Source></item><item><title>This weight loss drug can reduce your migraine days by half — it’s not Ozempic</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e49f82016d4283a4f533fe1abddd9e&amp;url=https%3a%2f%2fnypost.com%2f2025%2f06%2f25%2fhealth%2fweight-loss-drug-can-reduce-migraine-days-by-half-new-study%2f&amp;c=13773776808924465206&amp;mkt=en-us</link><description>Next-generation weight loss drugs may do more than shrink your waistline. A new study suggests that a medication in the same family as Ozempic could cut the number of days people suffer from migraines ...</description><pubDate>Wed, 25 Jun 2025 08:17:00 GMT</pubDate><News:Source>New York Post</News:Source></item><item><title>Diabetes drug Liraglutide cuts migraine days in half</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e49f82016d4283a4f533fe1abddd9e&amp;url=https%3a%2f%2fwww.yahoo.com%2fnews%2farticles%2fdiabetes-drug-liraglutide-cuts-migraine-115100448.html&amp;c=11788476912513161780&amp;mkt=en-us</link><description>Add Yahoo as a preferred source to see more of our stories on Google. Liraglutide slashes chronic migraine days in new study, showing promise as a treatment beyond weight loss. (CREDIT: Shutterstock) ...</description><pubDate>Fri, 26 Sep 2025 04:50:00 GMT</pubDate><News:Source>Yahoo</News:Source></item><item><title>Migraine Drug Could Be First To Treat Symptoms That Come Before The Headache</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e49f82016d4283a4f533fe1abddd9e&amp;url=https%3a%2f%2fwww.iflscience.com%2fmigraine-drug-could-be-first-to-treat-symptoms-that-come-before-the-headache-79178&amp;c=14482929508360696301&amp;mkt=en-us</link><description>Stephen has degrees in science (Physics major) and arts (English Literature and the History and Philosophy of Science), as well as a Graduate Diploma in Science Communication. Stephen has degrees in ...</description><pubDate>Mon, 12 May 2025 17:00:00 GMT</pubDate><News:Source>IFLScience</News:Source></item><item><title>Teva scores in appeal as court revives $177M verdict against Lilly in migraine patent spat</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e49f82016d4283a4f533fe1abddd9e&amp;url=https%3a%2f%2fwww.fiercepharma.com%2fpharma%2ftevas-migraine-patent-spat-lilly-federal-circuit-reverses-prior-loss-ajovy&amp;c=799285072883567078&amp;mkt=en-us</link><description>Following a quiet stretch, the legal back-and-forth over migraine meds from Teva and Eli Lilly has resurfaced, with Teva gaining favor on appeal after a reversal of its prior patent win in 2023.&amp;nb | ...</description><pubDate>Fri, 17 Apr 2026 07:16:00 GMT</pubDate><News:Source>Fierce Pharma</News:Source><News:Image>http://www.bing.com/th?id=ONUT.rr_m0K4KNOMNqQhzbomSZA&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>2121</News:ImageMaxWidth><News:ImageMaxHeight>1200</News:ImageMaxHeight></item><item><title>US appeals court revives Teva lawsuit against Eli Lilly over migraine drug</title><link>http://www.bing.com/news/apiclick.aspx?ref=FexRss&amp;aid=&amp;tid=69e49f82016d4283a4f533fe1abddd9e&amp;url=https%3a%2f%2fwww.reuters.com%2flegal%2flitigation%2fus-appeals-court-revives-teva-lawsuit-against-eli-lilly-over-migraine-drug-2026-04-16%2f&amp;c=5384246192752947511&amp;mkt=en-us</link><description>A U.S. appeals court on Thursday revived a patent lawsuit that Teva Pharmaceutical brought ​against Eli Lilly over the companies' competing migraine drugs, after ‌a judge previously overturned a $176.</description><pubDate>Thu, 16 Apr 2026 08:18:00 GMT</pubDate><News:Source>Reuters</News:Source><News:Image>http://www.bing.com/th?id=ONUT.f5brSoHmN7F-SHQ1F4JfQQ&amp;pid=News</News:Image><News:ImageSize>w={0}&amp;h={1}&amp;c=14</News:ImageSize><News:ImageMaxWidth>1920</News:ImageMaxWidth><News:ImageMaxHeight>1005</News:ImageMaxHeight></item></channel></rss>